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PSORIASIS is an ancient and puzzling disorder of the skin with a very variable
natural history. Nevertheless, complete clearance is extremely rare and therefore
perhaps worthy of recording.
CASE REPORT
The patient, a forty-three year old male, had psoriasis since the age of twelve
years. His brother and a niece have psoriasis, and his brother also has psoriatic
arthropathy. No previous family history of the condition is known. The usual local
treatment over the years produced little relief.
He came under the care of one of us (J.McE.), at the Nephrology Clinic some
years ago because of chronic renal failure on a basis of chronic -pyelonephritis.
This was managed conservatively with the usual fluid and dietary restrictions, but
the condition progressed and eventually became terminal in August, 1973. At that
stage he was admitted with a view to assessment for the chronic dialysis/transplant
programme.
He was seen at that time for assessment of his psoriasis (by A.M.T.K.). At this
stage he was noted to have extensive psoriasis involving trunk, limbs, palms of
hands, nails, and scalp. It was feared that the constructions of an arterio-venous
fistula to facilitate repeated dialysis might prove impractical because of the Koebner
phenomenon. An effort was made to control the psoriasis by the local application
of dilute steroid preparations resulting only in a complicating furunculosis which
responded to appropriate treatment. Nevertheless, an arteriovenous fistula was
constructed without complication and haemodialysis was commenced in September,
1973, twice weekly on Tuesdays and Fridays. Contrary to expectation psoriasis did
not develop in the fistula scar, nor at puncture sites, but rather his psoriasis began
to clear after the third dialysis. By the conclusion of the fourth treatment it was
completely gone. Bi-weekly dialysis was continued for twelve months until Sep-
tember, 1974, during which time no drugs were given. In September, 1974 a
successful renal transplant was carried out and followed up with the usual main-
tenance immunosuppressive therapy of prednisolone 20 mgs. daily and azothroprine
200 mgs. daily. In August, 1975 he remains clear from psoriatic lesions.
76DISCUSSION
Ingram (1964) regards psoriasis as an essentially epidermal disorder. He felt
however, that the subject-merited the attention of those working as physiologists
and pathologists because a better understanding of the disease might well uncover
some new pathological mechanism which could throw light on generalised disease
of obscure aetiology. In his opinion the mechanism of a disorder so common, yet
so unusual, could not concern the skin alone. Shuster (1971) reviewing the research
on the subject over the previous decade finds that all the recent work takes us back
again and again to the skin alone. He concludes that psoriasis remains a disease of
the skin itself, but he makes the point that this conclusion in no way excludes a
humoral component, though it does imply that any such component will only be
significant in relation to the skin.
The normal sequence of events whereby a basal cell becomes keratinized takes
twenty-five days. In psoriasis a similar process is accomplished in about four days
(Van Scott et al 1964; Weinstein and Van Scott 1965). Shuster feels that psoriasis
is a disease of faulty epidermopoiesis possibly due to impaired autocontrol mech-
anisms. A stimulator control has been suggested by some (Bullough 1967), an
inhibitory control is suggested by others (Hell 1970), but the exact cause of
psoriasis remains obscure.
Haemodialysis in this patient appears to have had a beneficial effect in the
clearance of his chronic psoriasis. This may have been purely coincidental. If the
disease is due to faulty epidermopoiesis caused by either a circulating humoral
stimulatory or inhibitory substance, one could speculate that haemodialysis had
removed this as yet unidentified psoriatic factor. One would have to postulate that
this factor is not capable of clearance by normal kidneys but is cleared perhaps
by adhesion to the dialysing membrane. In this case one would have expected the
psoriasis to recur following transplantation unless immunosuppressive therapy is
now the controlling factor. Had the donor been an identical twin immunosuppres-
sive agents would not have been required to prevent rejection (and possibly suppress
the psoriatic process), in which case the outcome would have been of even greater
interest.
We feel that it is worth reporting this single case
(a) because it may suggest some line of approach to those interested in research
into psoriasis, and
(b) because it seems to us that a few episodes of haemodialysis might be worth
trying in the more disabling forms of the disease.
SUMMARY
A male patient with chronic psoriasis since the age of twelve years commenced
haemodialysis for chronic renal failure in August, 1973. His psoriasis began to
clear after the third dialysis and remained clear throughout the entire year of twice
weekly dialysis, and subsequently following successful renal transplantation.
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